Manal Beshay1, Connie M Rhee2,3, Kamyar Kalantar-Zadeh2,3. 1. 3S Tech, Inc., Torrance. 2. Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange. 3. Tibor Rubin Veterans Affairs Long Beach Healthcare System, Long Beach, California, USA.
Abstract
PURPOSE OF REVIEW: Serum creatinine, urea, and cystatin C are the main biomarkers used to estimate glomerular filtration rates in persons with and without chronic kidney disease (CKD). Frequent measurements of these assays are needed to identify patients with earlier stages of CKD, detect episodes of acute kidney injury (AKI), and monitor for CKD progression. However, the cumbersome, time-consuming nature of conventional laboratory-based kidney function assays limit more frequent monitoring and greater patient self-management. RECENT FINDINGS: Noninvasive salivary assessments of creatinine, cystatin C, and urea make it feasible to conduct frequent monitoring of kidney function in point-of-care settings, as well as in nonclinical-care settings such as at home. Additionally, fingerstick sampling can offer an alternative route of blood testing that is suitable for home-based assessments. In this review, we provide an overview of emerging data on various salivary vs. fingerstick blood assessment methods for kidney function; their accuracy in comparison to 'gold-standard' laboratory-based methods; and their respective strengths and limitations in the clinical setting. SUMMARY: A practical, cost-effective, minimally invasive, multimarker assessment platform has the potential to circumvent the limitation of conventional laboratory blood-based testing approaches, and thereby address a major unmet need in the management of CKD patients.
PURPOSE OF REVIEW: Serum creatinine, urea, and cystatin C are the main biomarkers used to estimate glomerular filtration rates in persons with and without chronic kidney disease (CKD). Frequent measurements of these assays are needed to identify patients with earlier stages of CKD, detect episodes of acute kidney injury (AKI), and monitor for CKD progression. However, the cumbersome, time-consuming nature of conventional laboratory-based kidney function assays limit more frequent monitoring and greater patient self-management. RECENT FINDINGS: Noninvasive salivary assessments of creatinine, cystatin C, and urea make it feasible to conduct frequent monitoring of kidney function in point-of-care settings, as well as in nonclinical-care settings such as at home. Additionally, fingerstick sampling can offer an alternative route of blood testing that is suitable for home-based assessments. In this review, we provide an overview of emerging data on various salivary vs. fingerstick blood assessment methods for kidney function; their accuracy in comparison to 'gold-standard' laboratory-based methods; and their respective strengths and limitations in the clinical setting. SUMMARY: A practical, cost-effective, minimally invasive, multimarker assessment platform has the potential to circumvent the limitation of conventional laboratory blood-based testing approaches, and thereby address a major unmet need in the management of CKD patients.
Authors: M A Lie; B G Loos; Y M Henskens; M F Timmerman; E C Veerman; U van der Velden; G A van der Weijden Journal: J Clin Periodontol Date: 2001-10 Impact factor: 8.728
Authors: I Niculescu-Duvaz; L D'Mello; Z Maan; J L Barron; D J Newman; M E C Dockrell; J T C Kwan Journal: Kidney Int Date: 2006-04 Impact factor: 10.612
Authors: Jan Mares; David Stejskal; Jitka Vavrousková; Karel Urbánek; Roman Herzig; Petr Hlustík Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2003-12 Impact factor: 1.245
Authors: Carmen A Peralta; Ronit Katz; Mark J Sarnak; Joachim Ix; Linda F Fried; Ian De Boer; Walter Palmas; David Siscovick; Andrew S Levey; Michael G Shlipak Journal: J Am Soc Nephrol Date: 2010-12-16 Impact factor: 14.978